A Randomized, Double-Blind, Phase III Study of the Immunogenicity and Safety of a 9-Valent Human Papillomavirus L1 Virus-Like Particle Vaccine (V503) Versus Gardasil® in 9-15-Year-Old Girls

Timo Vesikari, Martine Baudin, Nicholas Brodszki, Pierre van Damme, Javier Diez-Domingo, Giancarlo Icardi, Lone Kjeld Petersen, Clément Tran, Stéphane Thomas, Luxembourg Alain

    Research output: Contribution to journalArticleScientificpeer-review

    74 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)992-998
    JournalPEDIATRIC INFECTIOUS DISEASE JOURNAL
    Volume34
    Issue number9
    DOIs
    Publication statusPublished - 2015
    Publication typeA1 Journal article-refereed

    Publication forum classification

    • Publication forum level 2

    Cite this